Rheumatoid Arthritis Real-world Management Over 20 Years. 2021

Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
E. Nikiphorou, MD (Res), Adjunct Senior Lecturer and Consultant Rheumatologist, F. Ibrahim, PhD, Research Fellow in Medical Statistics, D.L. Scott, MD, Emeritus Professor of Rheumatology, Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, UK.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D018501 Antirheumatic Agents Drugs that are used to treat RHEUMATOID ARTHRITIS. Anti-Rheumatic Agent,Anti-Rheumatic Drug,Antirheumatic Agent,Antirheumatic Disease-Modifying Second-Line Drug,Antirheumatic Drug,DMARD,Disease-Modifying Antirheumatic Drug,Disease-Modifying Antirheumatic Drugs,Anti-Rheumatic Agents,Anti-Rheumatic Agents, Non-Steroidal,Anti-Rheumatic Drugs,Antirheumatic Disease-Modifying Second-Line Drugs,Antirheumatic Drugs,Antirheumatic Drugs, Disease-Modifying,Disease-Modifying, Antirheumatic Second-Line Drugs,Agent, Anti-Rheumatic,Agent, Antirheumatic,Anti Rheumatic Agent,Anti Rheumatic Agents,Anti Rheumatic Agents, Non Steroidal,Anti Rheumatic Drug,Anti Rheumatic Drugs,Antirheumatic Disease Modifying Second Line Drug,Antirheumatic Disease Modifying Second Line Drugs,Antirheumatic Drug, Disease-Modifying,Antirheumatic Drugs, Disease Modifying,Disease Modifying Antirheumatic Drug,Disease Modifying Antirheumatic Drugs,Disease Modifying, Antirheumatic Second Line Drugs,Drug, Anti-Rheumatic,Drug, Antirheumatic,Drug, Disease-Modifying Antirheumatic,Non-Steroidal Anti-Rheumatic Agents

Related Publications

Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
May 2019, Clinical rheumatology,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
September 2014, Arthritis care & research,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
January 2003, Annals of the rheumatic diseases,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
May 2021, Expert opinion on biological therapy,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
February 2005, Annals of the rheumatic diseases,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
June 1991, The Quarterly journal of medicine,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
October 2023, RMD open,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
January 2016, Journal of medical economics,
Elena Nikiphorou, and Fowzia Ibrahim, and David L Scott
January 2021, Open access rheumatology : research and reviews,
Copied contents to your clipboard!